ACTU
ANALYST COVERAGE1 analysts
BUY
+758.9%upside to target
Buy
1100%
1 Buy (100%)0 Hold (0%)0 Sell (0%)
Full report →
PRICE
Prev Close
2.62
Open
2.71
Day Range2.41 – 2.71
2.41
2.71
52W Range1.58 – 11.99
1.58
11.99
8% of range
VOLUME & SIZE
Avg Volume
138.2K
FUNDAMENTALS
P/E Ratio
-2.5x
Not profitable
EPS (TTM)
Div Yield
No dividend
TECHNICAL
RSI (14)
40
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 102 days
Aug 28
Key MetricsTTM
Market Cap$58.50M
Revenue TTM$0.00
Net Income TTM-$21.54M
Free Cash Flow-$19.78M
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity-430.9%
Return on Assets-241.7%
Debt / Equity0.11
Current Ratio1.80
EPS TTM$-0.92

ACTU News

About

No description available.

Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Daniel SchmittChief Executive Officer, President & Director
Paul J. LytleChief Financial Officer
Alan KozikowskiScientific Founder and Advisor
Andrew MazarCo-Founder & Chief Operating Officer